SKURNIK M, STRAUCH E. Phage therapy: Facts and fiction [J]. International Journal of Medical Microbiology, 2006, 296:5-14.
[6]
NAKAI T, PARK S C. Bacteriophage therapy of infectious diseases in aquaculture [J]. Research in Microbiology, 2002, 153:13-18.
[7]
奥斯伯 F M, 布伦特 R, 金斯顿 E, 等. 精编分子生物学实验指南[M].第5版.金由辛,包慧中,赵丽云等译.北京:科学出版社, 2008: 39.
[8]
JIANG S C, KELLOGG C A, PAUL J H. Characterization of marine temperate phage-host systems isolated from Mamala Bay, Oahu, Hawaii [J]. Applied and Environmental Microbiology, 1998, 64(2):535-542.
[9]
GARNEAU J E, TREMBLAY D M, MOINEAU S. Characterization of 1706, a virulent phage from Lactococcus lactis with similarities to prophages from other Firmicutes [J]. Virology, 2008, 373:298-309.
BORYSOWSKI J, GORSKI A. Is phage therapy acceptable in the immunocompromised host? [J]. International Journal of Infectious Diseases, 2008, 12:466-471.
[22]
ADAMS M H. Bacteriophages[M]. Interscience Publishers, Inc., New York, 1959: 592.
[23]
萨姆布鲁克 J,拉塞尔 D W.分子克隆实验指南[M].第3版.黄培堂等译.北京:科学出版社, 2002:170-243.